Effects of Acute Prucalopride Administration in Healthy Volunteers
Launched by UNIVERSITY OF OXFORD · Mar 1, 2019
Trial Information
Current as of August 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female
- • Aged 18-40 years
- • Willing and able to give informed consent for participation in the study
- • Sufficiently fluent English to understand and complete the task
- Exclusion Criteria:
- • Current usage of psychoactive medication (except the contraceptive pill, the Depo-Provera injection or the progesterone implant)
- • Any past or current Axis 1 DSM-IV psychiatric disorder
- • Significant medical condition
- • Current or past gastro-intestinal disorder or irritable bowel syndrome
- • Current pregnancy or breastfeeding
- • Known lactate deficiency or any other problem absorbing lactose, galactose or glucose
- • Current or past history of drug or alcohol dependency
- • Participation in a psychological or medical study involving the use of medication within the last 3 months
- • Previous participation in a study using the same, or similar, emotional processing tasks
- • Smoker \> 5 cigarettes per day
- • Typically drinks \> 6 caffeinated drinks per day
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, , United Kingdom
Patients applied
Trial Officials
Susannah E Murphy, DPhil
Principal Investigator
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials